Amyloid Precursor Protein
Gangliosides are important players for controlling neuronal function and are directly involved in AD pathology. They are among the most potent stimulators of A[beta] production, are enriched in amyloid plaques and bind amyloid beta (A[beta]). However, the molecular mechanisms linking gangliosides wi...
Gespeichert in:
Veröffentlicht in: | PloS one 2012-03, Vol.7 (3), p.e34095 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Gangliosides are important players for controlling neuronal function and are directly involved in AD pathology. They are among the most potent stimulators of A[beta] production, are enriched in amyloid plaques and bind amyloid beta (A[beta]). However, the molecular mechanisms linking gangliosides with AD are unknown. Here we identified the previously unknown function of the amyloid precursor protein (APP), specifically its cleavage products A[beta] and the APP intracellular domain (AICD), of regulating GD3-synthase (GD3S). Since GD3S is the key enzyme converting a- to b-series gangliosides, it therefore plays a major role in controlling the levels of major brain gangliosides. This regulation occurs by two separate and additive mechanisms. The first mechanism directly targets the enzymatic activity of GD3S: Upon binding of A[beta] to the ganglioside GM3, the immediate substrate of the GD3S, enzymatic turnover of GM3 by GD3S was strongly reduced. The second mechanism targets GD3S expression. APP cleavage results, in addition to A[beta] release, in the release of AICD, a known candidate for gene transcriptional regulation. AICD strongly down regulated GD3S transcription and knock-in of an AICD deletion mutant of APP in vivo, or knock-down of Fe65 in neuroblastoma cells, was sufficient to abrogate normal GD3S functionality. Equally, knock-out of the presenilin genes, presenilin 1 and presenilin 2, essential for A[beta] and AICD production, or of APP itself, increased GD3S activity and expression and consequently resulted in a major shift of a- to b-series gangliosides. In addition to GD3S regulation by APP processing, gangliosides in turn altered APP cleavage. GM3 decreased, whereas the ganglioside GD3, the GD3S product, increased A[beta] production, resulting in a regulatory feedback cycle, directly linking ganglioside metabolism with APP processing and A[beta] generation. A central aspect of this homeostatic control is the reduction of GD3S activity via an A[beta]-GM3 complex and AICD-mediated repression of GD3S transcription. |
---|---|
ISSN: | 1932-6203 1932-6203 |
DOI: | 10.1371/journal.pone.0034095 |